Healthcare Opportunities

An Expert's View about Sales in Malaysia

Last updated: 12 Feb 2011

The growing economy has resulted in increased wealth spent on private healthcare. Malaysia sees an increase in demand for healthcare reflected by the increasing healthcare expenditure.

Sector briefing Healthcare Opportunities in Malaysia Why Malaysia? The growing economy has resulted in increased wealth spent on private healthcare. Malaysia sees an increase in demand for healthcare reflected by the increasing healthcare expenditure. The government handles 75% of Malaysia?s healthcare needs. Increasing number of elderly citizens have pushed healthcare to the top of the Malaysian government agenda with plans to increase the number of mobile healthcare clinics. Boosting the healthcare industry is one of the development objectives of the Malaysian Goverment during the 10th Five-Year Plan Find general information on Malaysian market (2010-2015). The Government will reform the conditions on UKTI?s website. The Doing healthcare delivery system with focus on 4 key Business Guide for Malaysia gives an overview areas: of Malaysia?s economy, business culture, ? Transforming delivery of the healthcare potential opportunities and an introduction to system other relevant issues. ? Increasing quality, capacity and coverage of the healthcare structure ?Malaysia sees an increase in ? Shifting towards wellness and disease prevention, rather than treatment; demand for healthcare ? Increasing the quality of human resources for health services reflected by the increasing healthcare expenditure.? UK Trade & Investment Sector briefing: Healthcare opportunities in Malaysia Opportunities ageing population which will cause a shortage of personnel. A total of 197 new c linics at the cost of RM637m (£127.4m), four new and 4 Pharmaceuticals rep lacement hospitals that will cost around RM600m Increasing healthcare costs and consumer (£145.5m) will be completed during the f awareness has boosted overall drug irst half of the plan period. consumption. Prescription and dispensing of Opportun medication is presently dealt with by general ities for UK healthcare companies in Malays practitioners which increases the overall value ia include: of the prescription market. There is also a Supp rising demand for treatment of chronic ly of innovative medical equipment and conditions. The Malaysian government has also devices placed a high priority to prevent and contain UK has trad diseases outbreaks. itionally success in supplying medical equ ipment to Malaysia. Malaysia Emphasis is given to the changing pattern of imports around 85% of the medical equipment and communicable and non-communicable diseases consumables used in the healthcare sectors. including mental health. Initiatives are undertaken to reform healthcare services and There are also planned investment in the the promotion of well being to the general expansion of med population. ical facilities both in the pr ivate and public sectors. There are opportun Multinationals control about 70% of the ities to supply and replace medical equ pharmaceutical market in terms of innovative ipment and provide E-Health Solutions, and specialised products. The local industry innovative medical devices and technology. remains focused on the production of generics Contract and lower-tech medicines. There is now an Manufacturing of Medical Devices expanding generics market due to rising costs. Malays ia has a developed strength in clean techno R & D logy. There is strong presence of estab lished supporting industries ranging from ster Malaysia is keen on joint research projects. The ilisation services, sterile medical packaging, precision eng government?s focus in developing the biotech ineering and tool & die making to contract manufactur sector will result in improved investment ing and assembly & mach opportunities which will be favourable for inery fabrication. A well educated, English speaking popu businesses and cost effective R & D lation, availability of the support propositions. There are also tax breaks and ing industries makes Malaysia an ideal concessions for foreign companies setting up. location for the manufacture of medical devices. Regional Collaborations Tra ining There is also an increasing demand on halal Institut medicine and products, which boots demand in ions of higher learning are keen to deve the Islamic world. Malaysia, a member of the lop healthcare courses and vocational train Organisation of Islamic Countries (OIC) ing that are internationally recognised. There are shortages of certain med provides access to other global Islamic ical pro markets. fessionals including pre-hospital and emergency care; ger iatrics and care of the e Malaysia also has increased trade and lderly and expanding post-basic training for al investment collaboration ties with China and lied healthcare personnel. therefore will benefit from this rising Dr importance. Malaysia is one of the six iven by increased affluence there is an Association of South East Asian Nations increasing number of private hospitals. Malays (ASEAN) nations that will have their Most ia is also becoming an attractive location for med Favoured Nations (MRN) rates on Chinese ical tourism. The demand for better services is driven by a growing as well as an goods reduced to 0% by 2010. In tandem, the UK Trade & Investment Sector briefing: Healthcare opportunities in Malaysia same rules apply to China which will enable www.protempgroup.com Malaysian goods to be duty-free to China. SEA Healthcare & Pharma Show The Ministry of Health announced that at least Dates: 6-8 April 2011 70% of the equity in services sector will be www.abcex.com opened to foreign participation under ASEAN Free Trade Agreement. Liberalisation of the Medical Hospital Malaysia 2011 healthcare sector will allow foreign corporation Dates: 29 June ? 1 July 2011 to open hospitals as well as foreign doctors and www.imshl.com insurance companies operate in Malaysia. Asia Medical 2011 Foreign healthcare companies in Malaysia Dates: 11-13 October 2011 www.asiamedical.org Compan ies with significant local production facilities in Malaysia include B Braun, GSK, UKTI contacts Johnson & Johnson and Ranbaxy. Other foreign owned drug companies with established Angie Yen presence in the market include Eli Lilly, GSK, Senior Manager for Trade & Investment Bayer, Agfa, Pfizer, Novartis, Merck & Co, British High Commission Sanofi-Aventis, Roche, Bristol-Meyer Squibb Tel: (00603) 2170 2268 and Boehringer. Email: angie.yen@fco.gov.uk www.ukti.gov.uk If you have any questions on the opportunities above, contact the UKTI Malaysia contacts named in this report. Business opportunities aimed specifically at UK companies are added daily to UKTI?s website. These leads are sourced by our staff overseas in British Embassies, High Commissions and Consulates, across all sectors and in over 100 markets. You can be alerted to opportunities in Malaysia on a regular basis by registering on the UKTI website. More on UKTI?s business opportunities service Major events and activities Find full details of all Healthcare related events on the UKTI website. New export events are added daily to the site and you can register to be alerted to them on a daily, weekly or monthly basis UKTI?s Tradeshow Access Programme (TAP) provides grant support for eligible Small & Medium Sized Enterprises (SME's) to attend trade shows overseas. Find out more about UKTI support for attendance at overseas events Other Healthcare Related Exhibitions in Malaysia BioMalaysia 2011 Dates: 21-24 Nov 2011 www.biomalaysia.com.my UK Trade & Investment Sector briefing: Healthcare opportunities in Malaysia Next steps - How UKTI can help ? Arranging appointments British companies wishing to develop their ? Organise seminars or other events for business in the Malaysian market are advised you to meet contacts and promote your to undertake as much market research and company in the Malaysian market planning as possible in the UK. UKTI?s team in Malaysia, with its wide local knowledge and This work is available via our Overseas Market experience, can provide a range of services to Introduction Service (OMIS) a chargeable British-based companies wishing to grow their service which assists British-based companies business in the Malaysian market. wishing to enter or expand their business in overseas markets. This can include: ? Provision of market information To find out more about commissioning this ? Validated lists of agents/distributors work, or accessing other UKTI services and ? Key market players or potential specialist advice, please visit the UKTI website customers in the Malaysian market to find contact details for your local UKTI ? Establishment of interest of such office. contacts in working with you Whereas every effort has been made to ensure that the information given in this document is accurate, neither UK Trade & Investment nor its parent Departments (the Department for Business, Innovation & Skills, and the Foreign & Commonwealth Office), accept liability for any errors, omissions or misleading statements, and no warranty is given or responsibility accepted as to the standing of any individual, firm, company or other organisation mentioned. Published 2010 by UK Trade & Investment. Crown Copyright © UK Trade & Investment Sector briefing: Healthcare opportunities in Malaysia
Posted: 26 January 2011, last updated 12 February 2011

See more from Sales in Malaysia

Expert Views    
Healthcare Opportunities   By UK Trade & Investment
Construction Opportunities   By UK Trade & Investment
ICT & Creative Media Oppty   By UK Trade & Investment
Presenting the contributor